204 related articles for article (PubMed ID: 24949795)
1. In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer.
Wong YY; Hyde Z; McCaul KA; Yeap BB; Golledge J; Hankey GJ; Flicker L
PLoS One; 2014; 9(6):e99954. PubMed ID: 24949795
[TBL] [Abstract][Full Text] [Related]
2. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
3. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
Dimitrakopoulou VI; Tsilidis KK; Haycock PC; Dimou NL; Al-Dabhani K; Martin RM; Lewis SJ; Gunter MJ; Mondul A; Shui IM; Theodoratou E; Nimptsch K; Lindström S; Albanes D; Kühn T; Key TJ; Travis RC; Vimaleswaran KS; ; ; ; Kraft P; Pierce BL; Schildkraut JM
BMJ; 2017 Oct; 359():j4761. PubMed ID: 29089348
[No Abstract] [Full Text] [Related]
4. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
[TBL] [Abstract][Full Text] [Related]
5. Higher thyrotropin concentration is associated with increased incidence of colorectal cancer in older men.
Chan YX; Alfonso H; Chubb SA; Fegan PG; Hankey GJ; Golledge J; Flicker L; Yeap BB
Clin Endocrinol (Oxf); 2017 Feb; 86(2):278-285. PubMed ID: 27809335
[TBL] [Abstract][Full Text] [Related]
6. Associations between testosterone levels and incident prostate, lung, and colorectal cancer. A population-based study.
Hyde Z; Flicker L; McCaul KA; Almeida OP; Hankey GJ; Chubb SA; Yeap BB
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1319-29. PubMed ID: 22828207
[TBL] [Abstract][Full Text] [Related]
7. Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men.
Chan YX; Alfonso H; Chubb SA; Handelsman DJ; Fegan PG; Hankey GJ; Golledge J; Flicker L; Yeap BB
Horm Cancer; 2017 Apr; 8(2):119-126. PubMed ID: 28233278
[TBL] [Abstract][Full Text] [Related]
8. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
[TBL] [Abstract][Full Text] [Related]
9. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study.
Jenab M; Bueno-de-Mesquita HB; Ferrari P; van Duijnhoven FJ; Norat T; Pischon T; Jansen EH; Slimani N; Byrnes G; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Kaaks R; Linseisen J; Boeing H; Bergmann MM; Trichopoulou A; Misirli G; Trichopoulos D; Berrino F; Vineis P; Panico S; Palli D; Tumino R; Ros MM; van Gils CH; Peeters PH; Brustad M; Lund E; Tormo MJ; Ardanaz E; Rodríguez L; Sánchez MJ; Dorronsoro M; Gonzalez CA; Hallmans G; Palmqvist R; Roddam A; Key TJ; Khaw KT; Autier P; Hainaut P; Riboli E
BMJ; 2010 Jan; 340():b5500. PubMed ID: 20093284
[TBL] [Abstract][Full Text] [Related]
10. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT
Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842
[TBL] [Abstract][Full Text] [Related]
11. Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.
McCullough ML; Zoltick ES; Weinstein SJ; Fedirko V; Wang M; Cook NR; Eliassen AH; Zeleniuch-Jacquotte A; Agnoli C; Albanes D; Barnett MJ; Buring JE; Campbell PT; Clendenen TV; Freedman ND; Gapstur SM; Giovannucci EL; Goodman GG; Haiman CA; Ho GYF; Horst RL; Hou T; Huang WY; Jenab M; Jones ME; Joshu CE; Krogh V; Lee IM; Lee JE; Männistö S; Le Marchand L; Mondul AM; Neuhouser ML; Platz EA; Purdue MP; Riboli E; Robsahm TE; Rohan TE; Sasazuki S; Schoemaker MJ; Sieri S; Stampfer MJ; Swerdlow AJ; Thomson CA; Tretli S; Tsugane S; Ursin G; Visvanathan K; White KK; Wu K; Yaun SS; Zhang X; Willett WC; Gail MH; Ziegler RG; Smith-Warner SA
J Natl Cancer Inst; 2019 Feb; 111(2):158-169. PubMed ID: 29912394
[TBL] [Abstract][Full Text] [Related]
12. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study.
Sun YQ; Langhammer A; Wu C; Skorpen F; Chen Y; Nilsen TIL; Romundstad PR; Mai XM
Eur J Epidemiol; 2018 Jan; 33(1):67-77. PubMed ID: 29080012
[TBL] [Abstract][Full Text] [Related]
13. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.
Barnett CM; Nielson CM; Shannon J; Chan JM; Shikany JM; Bauer DC; Hoffman AR; Barrett-Connor E; Orwoll E; Beer TM
Cancer Causes Control; 2010 Aug; 21(8):1297-303. PubMed ID: 20383574
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
16. Low vitamin D status is an independent predictor of increased frailty and all-cause mortality in older men: the Health in Men Study.
Wong YY; McCaul KA; Yeap BB; Hankey GJ; Flicker L
J Clin Endocrinol Metab; 2013 Sep; 98(9):3821-8. PubMed ID: 23788685
[TBL] [Abstract][Full Text] [Related]
17. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology.
Vashi PG; Trukova K; Lammersfeld CA; Braun DP; Gupta D
Nutr J; 2010 Nov; 9():60. PubMed ID: 21092237
[TBL] [Abstract][Full Text] [Related]
18. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Hofmann JN; Yu K; Horst RL; Hayes RB; Purdue MP
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):927-31. PubMed ID: 20332255
[TBL] [Abstract][Full Text] [Related]
19. Association among plasma 1,25(OH)
Ramakrishnan S; Steck SE; Arab L; Zhang H; Bensen JT; Fontham ETH; Johnson CS; Mohler JL; Smith GJ; Su LJ; Woloszynska A
Prostate; 2019 Jul; 79(10):1117-1124. PubMed ID: 31077420
[TBL] [Abstract][Full Text] [Related]
20. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men.
Lee DM; Vanderschueren D; Boonen S; O'Neill TW; Pendleton N; Pye SR; Ravindrarajah R; Gielen E; Claessens F; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC;
Age Ageing; 2014 Jul; 43(4):528-35. PubMed ID: 24375224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]